Diabetes mellitus and APOL1 genotype increase the risk for chronic kidney disease progression in sickle cell disease

2.

Zahr

RS

,

Rampersaud

E

,

Kang

G

, et al.

Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life

.

Haematologica

.

2019

;

104

(

9

):

e385

-

e387

.

3.

Saraf

SL

,

Shah

BN

,

Zhang

X

, et al.

APOL1, alpha-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia

.

Haematologica

.

2017

;

102

(

1

):

e1

-

e6

.

4.

Parsa

A

,

Kao

WH

,

Xie

D

, et al.

APOL1 risk variants, race, and progression of chronic kidney disease

.

N Engl J Med

.

2013

;

369

(

23

):

2183

-

2196

.

5.

Zhou

J

,

Han

J

,

Nutescu

EA

, et al.

Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis

.

Br J Haematol

.

2019

;

185

(

1

):

116

-

127

.

6.

Zhou

J

,

Calip

GS

,

Nutescu

EA

, et al.

Type 2 diabetes mellitus burdens among adults with sickle cell disease: a 12-year single health system-based cohort analysis

.

EJHaem

.

2021

;

2

(

1

):

94

-

98

.

7.

Cheng

YJ

,

Kanaya

AM

,

Araneta

MRG

, et al.

Prevalence of diabetes by race and ethnicity in the United States, 2011-2016

.

JAMA

.

2019

;

322

(

24

):

2389

-

2398

.

8.

Inker

LA

,

Eneanya

ND

,

Coresh

J

, et al.

New creatinine- and cystatin C-based equations to estimate GFR without race

.

N Engl J Med

.

2021

;

385

(

19

):

1737

-

1749

.

9.

Olaniran

KO

,

Allegretti

AS

,

Zhao

SH

, et al.

Kidney function decline among Black patients with sickle cell trait and sickle cell disease: an observational cohort study

.

J Am Soc Nephrol

.

2020

;

31

(

2

):

393

-

404

.

10.

Derebail

VK

,

Ciccone

EJ

,

Zhou

Q

,

Kilgore

RR

,

Cai

J

,

Ataga

KI

.

Progressive decline in estimated GFR in patients with sickle cell disease: an observational cohort study

.

Am J Kidney Dis

.

2019

;

74

(

1

):

47

-

55

.

11.

American Diabetes Association

.

About diabetes: examine the facts

. Accessed 30 October 2024. https://diabetes.org/about-diabetes/statistics.

12.

Friedman

DJ

,

Kozlitina

J

,

Genovese

G

,

Jog

P

,

Pollak

MR

.

Population-based risk assessment of APOL1 on renal disease

.

J Am Soc Nephrol

.

2011

;

22

(

11

):

2098

-

2105

.

13.

Lacy

ME

,

Wellenius

GA

,

Sumner

AE

, et al.

Association of sickle cell trait with hemoglobin A1c in African Americans

.

JAMA

.

2017

;

317

(

5

):

507

-

515

.

14.

Heerspink

HJL

,

Stefánsson

BV

,

Correa-Rotter

R

, et al.

Dapagliflozin in patients with chronic kidney disease

.

N Engl J Med

.

2020

;

383

(

15

):

1436

-

1446

.

15.

Egbuna

O

,

Zimmerman

B

,

Manos

G

, et al.

Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants

.

N Engl J Med

.

2023

;

388

(

11

):

969

-

979

.